DIN 02453916 — TEVA-BUPRENORPHINE/NALOXONE 8 MG; 2 MG
TEVA-BUPRENORPHINE/NALOXONE is a tablet of Buprenorphine / Naloxone marketed by TEVA CANADA LIMITED. The full Buprenorphine / Naloxone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02453916
- Brand name
- TEVA-BUPRENORPHINE/NALOXONE
- Active ingredient
- Buprenorphine / Naloxone
- Strength
- 8 MG; 2 MG
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Opioid partial agonist / opioid antagonist combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Buprenorphine / Naloxone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02424851 | PMS-BUPRENORPHINE-NALOXONE | 2 MG; 0.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02424878 | PMS-BUPRENORPHINE-NALOXONE | 2 MG; 8 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02502321 | SUBOXONE | 1 MG; 4 MG | FILM (SOLUBLE) | INDIVIOR UK LIMITED | MARKETED |
| 02468085 | SUBOXONE | 12 MG; 3 MG | TABLET | INDIVIOR UK LIMITED | MARKETED |
| 02502356 | SUBOXONE | 12 MG; 3 MG | FILM (SOLUBLE) | INDIVIOR UK LIMITED | MARKETED |
| 02295695 | SUBOXONE | 2 MG; 0.5 MG | TABLET | INDIVIOR UK LIMITED | MARKETED |
| 02502313 | SUBOXONE | 2 MG; 0.5 MG | FILM (SOLUBLE) | INDIVIOR UK LIMITED | MARKETED |
| 02502348 | SUBOXONE | 2 MG; 8 MG | FILM (SOLUBLE) | INDIVIOR UK LIMITED | MARKETED |
| 02468093 | SUBOXONE | 4 MG; 16 MG | TABLET | INDIVIOR UK LIMITED | MARKETED |
| 02295709 | SUBOXONE | 8 MG; 2 MG | TABLET | INDIVIOR UK LIMITED | MARKETED |
| 02453908 | TEVA-BUPRENORPHINE/NALOXONE | 0.5 MG; 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED |